Atrinsic Inc. (PTIX) vs Silexion Therapeutics Corp (SLXN)
Atrinsic Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Silexion Therapeutics Corp is the larger, with a market value of $1.4M against $1.3M — 1.1× the size. Silexion Therapeutics Corp has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 9 metrics below, Atrinsic Inc. leads on 6 and Silexion Therapeutics Corp on 3.
Valuation
Profitability
| Metric | PTIX | SLXN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (338.24%) | (17,021.95%) | (57.72%) |
| Return on assets | 390.69% | (277.96%) | (49.22%) |
| Return on invested capital | (229.86%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack